Rochester Skin Lymphoma Medical Group — Fairport, New York

Rochester Skin Lymphoma Medical Group is a clinical research site located in Fairport, New York, United States 14450.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

Rochester Skin Lymphoma Medical Group has participated in 5 clinical trials with 1 currently active.

Therapeutic areas: Cutaneous T-Cell Lymphoma/Mycosis Fungoides, CTCL/ Mycosis Fungoides, CTCL.

Sponsors: miRagen Therapeutics, Inc., Soligenix.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rochester Skin Lymphoma Medical Group?

Rochester Skin Lymphoma Medical Group has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rochester Skin Lymphoma Medical Group conducted?

Rochester Skin Lymphoma Medical Group has 5 clinical trials on record, with 1 currently active. Their work covers Cutaneous T-Cell Lymphoma/Mycosis Fungoides, CTCL/ Mycosis Fungoides, CTCL.

Is Rochester Skin Lymphoma Medical Group accredited by Crixeo Health?

Rochester Skin Lymphoma Medical Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rochester Skin Lymphoma Medical Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.